Source: Getty Images
The CDC’s Advisory Committee on Immunization Practices meets today to review the data that have led, “out of an abundance of caution,” to a recommended pause in the use of J&J’s COVID-19 vaccine in the U.S. The focus is on six cases of what appears to be a very rare but severe type of blood clot, all occurring in women ages 18 to 48, with symptoms developing six to 13 days after vaccination. One woman died and another is hospitalized in critical condition.
Nearly 7 million doses of the single-dose J&J vaccine have been given in this country. The concern is a clot known as cerebral venous sinus thrombosis, occurring in combination with low blood platelets. Traditional treatments for clots, such as heparin, may actually be dangerous in this situation. The CDC and FDA are advising that anyone who has received the J&J vaccine and develops severe headache, abdominal pain, leg pain or shortness of breath within three weeks of being vaccinated should contact
В Нью-Йорке распространяется новый штамм коронавируса tatar-inform.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tatar-inform.ru Daily Mail and Mail on Sunday newspapers.
The makers of coronavirus vaccines are learning how to change their vaccines to deal with virus mutations. Experts are looking to influenza, or flu, vaccines to help them understand if and when the shots may need to be changed.
The good news: Many of the new COVID-19 vaccines are made with new, flexible technology that’s easy to upgrade. What’s harder: Deciding if the virus has mutated enough that it’s time to modify vaccines and what changes to make.
COVID-19 vaccine shots might be tweaked if variants get worse cdispatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cdispatch.com Daily Mail and Mail on Sunday newspapers.